We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$95.5B
1-Year Est. Return
28.4%
This Fund
S&P 500
This Quarter
Est. Return
+8.8%
1 Year Est. Return
+28.4%
3 Year Est. Return
+84.58%
5 Year Est. Return
+116.72%
10 Year Est. Return
+426.49%
AUM
$83B
AUM Growth
+$4.08B
(+5.2%)
Cap. Flow
-$2.07B
Cap. Flow
% of AUM
-2.5%
Top 10 Holdings %
Top 10 Hldgs %
13.18%
Holding
730
New
59
Increased
161
Reduced
398
Closed
45
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Keurig Dr Pepper
KDP
|
+$550M |
| 2 |
Fidelity National Information Services
FIS
|
+$353M |
| 3 |
Global Payments
GPN
|
+$263M |
| 4 |
CVS Health
CVS
|
+$175M |
| 5 |
Devon Energy
DVN
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$433M |
| 2 |
Lowe's Companies
LOW
|
+$277M |
| 3 |
Oracle
ORCL
|
+$226M |
| 4 |
Progressive
PGR
|
+$220M |
| 5 |
Las Vegas Sands
LVS
|
+$167M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.96% |
| 2 | Healthcare | 15.3% |
| 3 | Industrials | 15.12% |
| 4 | Technology | 14.91% |
| 5 | Consumer Discretionary | 11.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
AutoZone
AZO
$47.7B
| $1.51B | 1.81% |
718,513
-41,452
| -5% | -$77.2M |
|
2
Johnson & Johnson
JNJ
$624B
| $1.37B | 1.64% |
7,980,625
+174,936
| +2% | +$28.6M |
|
3
JPMorgan Chase
JPM
$930B
| $1.22B | 1.47% |
7,678,016
-346,061
| -4% | -$56.8M |
|
4
ConocoPhillips
COP
$146B
| $1.14B | 1.37% |
15,771,279
-476,829
| -3% | -$34.7M |
|
5
Eaton
ETN
$161B
| $1.02B | 1.23% |
5,918,629
-275,006
| -4% | -$45.6M |
|
6
Cisco
CSCO
$444B
| $978M | 1.18% |
15,439,621
-1,877,050
| -11% | -$107M |
|
|
FITB
7
Fifth Third Bancorp
FITB
$51.8B
| $977M | 1.18% |
22,406,711
-1,803,811
| -7% | -$78.9M |
|
8
DuPont de Nemours
DD
$18.6B
| $957M | 1.15% |
9,435,103
-605,134
| -6% | -$57.6M |
|
9
Centene
CNC
$31.5B
| $892M | 1.07% |
10,838,200
+1,317,451
| +14% | +$96.5M |
|
10
Cigna
CI
$75.7B
| $891M | 1.07% |
3,879,114
-60,544
| -2% | -$12.9M |
|
11
Bank of America
BAC
$430B
| $885M | 1.07% |
19,862,308
-2,261,329
| -10% | -$103M |
|
12
Alphabet (Google) Class A
GOOGL
$3.89T
| $879M | 1.06% |
6,071,500
-263,200
| -4% | -$37.9M |
|
13
Truist Financial
TFC
$62.5B
| $865M | 1.04% |
14,760,911
-482,782
| -3% | -$29.5M |
|
14
UnitedHealth
UNH
$385B
| $849M | 1.02% |
1,692,760
-85,524
| -5% | -$38.7M |
|
15
Qualcomm
QCOM
$180B
| $834M | 1% |
4,558,923
+197,544
| +5% | +$31.6M |
|
16
Berkshire Hathaway Class B
BRK.B
$1.06T
| $833M | 1% |
2,782,811
-155,242
| -5% | -$44.5M |
|
17
Avantor
AVTR
$7.75B
| $798M | 0.96% |
18,965,498
-615,160
| -3% | -$24.2M |
|
18
Dover
DOV
$26.6B
| $773M | 0.93% |
4,258,831
-95,673
| -2% | -$16.2M |
|
|
19
Fidelity National Information Services
FIS
$20.7B
| $768M | 0.93% |
7,031,348
+3,127,602
| +80% | +$353M |
|
20
Marathon Petroleum
MPC
$91.2B
| $765M | 0.92% |
11,931,734
-369,278
| -3% | -$23.7M |
|
21
KeyCorp
KEY
$24.4B
| $752M | 0.91% |
32,510,696
-822,714
| -2% | -$19.1M |
|
22
Qorvo
QRVO
$7.65B
| $742M | 0.89% |
4,746,394
+809,212
| +21% | +$129M |
|
23
AbbVie
ABBV
$454B
| $737M | 0.89% |
5,439,559
+379,250
| +7% | +$44.8M |
|
|
PXD
24
DELISTED
Pioneer Natural Resource Co.
PXD
| $730M | 0.88% |
4,008,631
-119,767
| -3% | -$22M |
|
25
SLB Ltd
SLB
$70.6B
| $725M | 0.87% |
24,189,830
+1,474,462
| +6% | +$46.4M |
|
Similar funds
Boston Partners's Q4 2021 Portfolio in Review
As of Q4 2021, Boston Partners held 730 positions worth $83B, up 5.2% from $78.9B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Boston Partners's Q4 2021 filing shows 59 new, 161 increased, 398 reduced and 45 closed positions. Its largest new stake was Keurig Dr Pepper: 15,605,496 shares worth $575M. The largest sale was Pfizer, an estimated $433M.
By sector, the portfolio is most concentrated in Financials at 20% of assets, down from 22% a quarter earlier, followed by Healthcare and Industrials.
- Boston Partners's largest Q4 2021 buy was Keurig Dr Pepper: 15,605,496 shares worth $575M.
- Boston Partners added most to Fidelity National Information Services in Q4 2021, an estimated $353M increase.
- Boston Partners's biggest Q4 2021 reduction was Pfizer, cutting an estimated $433M.
- Boston Partners fully exited CyrusOne Inc Common Stock in Q4 2021, selling an estimated $137M.
- Boston Partners's ten largest holdings make up 13% of its $83B portfolio in Q4 2021.
- Boston Partners opened 59 new positions and closed 45 in Q4 2021.
- Boston Partners's portfolio value rose 5.2% quarter-over-quarter to $83B.
Based on Boston Partners's 13F filing for Q4 2021, filed 4 Feb 2022.